🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Dana M. Roque

Gynecologic Oncology Group

ORCID: 0000-0002-7098-6376

Also affiliated with University of Maryland, Baltimore, University of Maryland Medical Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

MedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability”.

A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability

Cancer(2021)10.1002/cncr.34025

N/A

2.4DataRank · unranked

80 citations

Dana M. Roque, Eric R. Siegel, Natália Buza, Pei Hui, Elena Bonazzoli +28 more

A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)

Annals of Oncology(2021)10.1016/j.annonc.2021.04.013

N/A

1.9DataRank · unranked

50 citations

Dana M. Roque, Eric R. Siegel, Natália Buza, Pei Hui, Elena Bonazzoli +28 more

Evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy

Translational Oncology(2021)10.1016/j.tranon.2021.101198

N/A

0.604DataRank · unranked

13 citations

Aaron J. Sorrin, Xiaocong Pu, Cindy Liu, Jocelyn Reader, Dana M. Roque +2 more

Fluorescence-guided photoimmunotherapy using targeted nanotechnology and ML7710 to manage peritoneal carcinomatosis

Science Advances(2023)10.1126/sciadv.adi3441

N/A

0DataRank · unranked

20 citations

Sumiao Pang, Robert Perttilä, Chen‐Hua Ma, Payal Srivastava, Brandon Gaitan +9 more

Transient fluid flow improves photoimmunoconjugate delivery and photoimmunotherapy efficacy

iScience(2023)10.1016/j.isci.2023.107221

N/A

0DataRank · unranked

7 citations

Keri Zhou, K.N. May, Cindy Liu, Kathryn McNaughton, Idrisa Rahman +5 more

Co-Packaged PARP inhibitor and photosensitizer for targeted photo-chemotherapy of 3D ovarian cancer spheroids

Cell & Bioscience(2024)10.1186/s13578-024-01197-6

N/A

0DataRank · unranked

4 citations

Anika Dasgupta, Kathryn McNaughton, Carla Arnau del Valle, Keri Zhou, Cindy Liu +3 more

Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response

Cancers(2021)10.3390/cancers13174318

N/A

0DataRank · unranked

155 citations

Christina Conrad, Aaron J. Sorrin, Mustafa Kemal Ruhi, Jocelyn Reader, Stephanie Huang +9 more

Cervical Cancer Outcomes in Women With HIV in the Age of Antiretroviral Therapy

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.27389

N/A

0DataRank · unranked

1 citations

Rehema Thomas, Austin Huang, Anushka S Mandalapu, Dana M. Roque, Kristina Bowles +8 more

Photodynamic Priming Improves the Anti-Migratory Activity of Prostaglandin E Receptor 4 Antagonist in Cancer Cells In Vitro

Cancers(2021)10.3390/cancers13215259

N/A

0DataRank · unranked

8 citations

Cindy Liu, Julia Cicalo, Jocelyn Reader, Daniel Najafali, Yuji Zhang +3 more

Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2201423119

N/A

0DataRank · unranked

10 citations

Nisha R. Pawar, Erik W. Martin, Marguerite S. Buzza, Gregory D. Conway, Rena G. Lapidus +7 more